Clinical and Radiological Outcomes of Medacta Shoulder System FR
Clinical and Radiological Outcomes of Medacta Shoulder System
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Arianna Girardi
- Phone Number: +41 91 696 60 60
- Email: girardi@medacta.ch
Study Locations
-
-
-
Annecy, France, 74000
- Recruiting
- Clinique Générale Annecy
-
Contact:
- Bruno Toussaint, Dr
- Phone Number: 04 50 33 09 50
- Email: bruno.toussaint10@wanadoo.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients older than 18 years
- Patient with one of the following diagnosis:
Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty
Exclusion Criteria:
- Patients with malignant diseases (at the time of surgery)
- Patients with proven or suspect infections (at the time of surgery)
- Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
- Patients with known incompatibility or allergy to products materials (at the time of surgery)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Survival Rate
Time Frame: 10 years
|
Kaplan Meier method
|
10 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse events
Time Frame: up to 10 years
|
record of adverse event
|
up to 10 years
|
|
Clinical outcome evaluating Constant & Murley Score
Time Frame: 1, 2, 5 and 10 years
|
Constant & Murley Score (CMS): The CMS is a multi-item functional scale assessing pain, ADL, ROM and strength of the affected shoulder.
Its score ranges from 0 to 100 points, representing worst and best shoulder function, respectively
|
1, 2, 5 and 10 years
|
|
Functional outcome evaluating Oxford Shoulder Score
Time Frame: 1, 2, 5 and 10 years
|
Oxford Shoulder Score (OSS): The Oxford Shoulder Score is a unidimensional score comprising 12 questions.
Starting with 1 (best/fewest symptoms) to 5 (worst/most severe) which is awarded to correspond to the patient's symptoms.
The total gives a minimum score of 12 and a maximum of 60.
A higher score implies a greater degree of disability.
|
1, 2, 5 and 10 years
|
|
Radiographic performance of the implants evaluating presence of radiolucencies
Time Frame: 3 months, 1, 2, 5 and 10 years
|
presence of radiolucencies
|
3 months, 1, 2, 5 and 10 years
|
|
Patient evaluation quality of life
Time Frame: 1, 2, 5 and 10 years
|
EQ-5D-5L: The EQ-5D-5L is a self-assessed, health related, quality of life questionnaire.
The scale measures quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
Typically it is calculated by assigning a numerical value to each response level (i.e., 1 for "no problems", 5 for "extreme problems"/"unable to") and summing these values across the five items, resulting in a score from 5 (no problems on any dimension) to 25 (extreme problems on all dimensions)
|
1, 2, 5 and 10 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Bruno Toussaint, Clinique Générale Annecy
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- P06.001.03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.